OTC Vending Machines? Meet Zur Rose’s Latest Experiment In Automated Pharmacy

As well as trying to become the Amazon of European healthcare, Swiss supply chain distruptor Zur Rose continues to experiment with automated pharmacy models with an OTC vending machine in Kirchberg.

Automation
Zur Rose Continues To Experiment With Automated Pharmacy Models • Source: Shutterstock

European supply chain disruptor Zur Rose Group AG has launched in Switzerland its latest experiment in automated pharmacy: a vending machine that dispenses natural medicines, dietary supplements and personal care products.

A collaboration with vending machine specialistSelecta TMP AG, ApoBox dispenses to consumers in Kirchberg – a small village in the Swiss canton of Bern – natural medicines such as Bach...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Retail

OTCs Are ‘Beacon Of Hope’ For Austrian Pharmacy

 
• By 

Just under half of Austrian pharmacists surveyed by Elpato Medien are “convinced that the OTC business will ensure the survival of their pharmacy.”

Germans Favor Bricks-And-Mortar Pharmacy Over Mail-Order For OTCs

 
• By 

Almost two thirds (62%) of respondents to an online survey said they would rather buy non-prescription medicines in a local pharmacy than via a mail-order pharmacy, Pharma Deutschland reports.

JCPenney’s Online Beauty Shopper Conversion, Order Value Jump Thanks To Virtual Try-On

 

Retailer JC Penney Company, Inc.’s use of Revieve Inc.’s virtual try-on and beauty advisor tools has driven significant increases in online engagement, average order rates and conversion rates for makeup, skin and hair care versus the retailer’s other e-commerce products.

False Advertising Challenges To OTC Phenylephrine Efficacy Ineffective Against Federal Preemption

 

Although FDA concluded OTC oral phenylephrine is ineffective as a nasal decongestant in doses up to highest studied level, federal preemption precludes challenges to agency’s regulation of labeling for phenylephrine and other Rx and OTC drugs, according to recent decision in New York federal court.

More from Business

People On The Move: Appointments At ANEPF, Inula, Opella

 
• By 

A round-up of the latest consumer health people moves: ANEFP elects president; Inula Group appoints CEO; Opella names ANZ head.

Over The Counter: Taking Real-World Evidence Seriously, With IQVIA Consumer Health’s Volker Spitzer

 
• By 

In part 2 of HBW Insight's interview, IQVIA Consumer Health's vice president of global research and development and real-world evidence services, Volker Spitzer, explains how to approach real world evidence so that regulators recognize its validity, in supporting Rx-to-OTC switch applications, for example.

Recordati Relying On OTC To Act As ‘Booster’ To Growth

 
• By 

In categories like cough & cold and gastrointestinal, OTC products have a pivotal role to play in helping Recordati hit its sales targets for the 2025-2027 period.